Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer

Introduction: In our previous studies it was concluded that the zinc (Zn) level in in human expressed prostatic fluid (EPF) is a first candidate with the role of offering a new, simple, fast, reliable, and non-invasive diagnostic tool for prostate cancer (PCa) screening. However it was unclear how o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vladimir Zaichick, Sofia Zaichick
Formato: article
Lenguaje:EN
Publicado: Emergency Department of Hospital San Pedro (Logroño, Spain) 2020
Materias:
Acceso en línea:https://doaj.org/article/8a0b5467256b4f20b260e2cdff836c63
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8a0b5467256b4f20b260e2cdff836c63
record_format dspace
spelling oai:doaj.org-article:8a0b5467256b4f20b260e2cdff836c632021-12-02T15:37:04ZZinc concentrations in the expressed prostatic fluid of patients with bladder cancer10.5281/zenodo.37862672695-5075https://doaj.org/article/8a0b5467256b4f20b260e2cdff836c632020-07-01T00:00:00Zhttps://doi.org/10.5281/zenodo.3786267https://doaj.org/toc/2695-5075Introduction: In our previous studies it was concluded that the zinc (Zn) level in in human expressed prostatic fluid (EPF) is a first candidate with the role of offering a new, simple, fast, reliable, and non-invasive diagnostic tool for prostate cancer (PCa) screening. However it was unclear how other non-prostatic diseases inherent of the old persons, including heart diseases, atherosclerosis, diabetes, asymptomatic cancer of different localization and some others, impact on a chemical element composition of expressed prostatic fluid. Thus, the purpose of this study was to evaluate whether significant changes in the levels of Zn in EPF exist in patients with bladder cancer (BC). Methods: Prostatic fluid levels of Zn were prospectively evaluated in 17 patients with BC and 51 healthy male inhabitants (control group). Measurements were performed using 109Cd radionuclide-induced energy dispersive X-ray fluorescent microanalysis developed by us. Results: Mean value  standard deviation of mean (MSD) for concentration of Zn in the EPF of healthy males and patients with BC was 573202 mg/L and 625±108 mg/L, respectively. Using both parametric Student’s t-test and non-parametric Wilcoxon-Mann-Whitney U-test it was shown that the Zn concentration in the EPF of patients with BC did not differ from that in healthy subjects. Conclusion: Such serious illness as BC did not impact on the Zn concentration in the EPF.Vladimir ZaichickSofia ZaichickEmergency Department of Hospital San Pedro (Logroño, Spain)articleprostate cancerbladder cancerexpressed prostatic fluidzincenergy-dispersive x-ray fluorescent analysisMedicine (General)R5-920ENIberoamerican Journal of Medicine, Vol 2, Iss 3, Pp 167-171 (2020)
institution DOAJ
collection DOAJ
language EN
topic prostate cancer
bladder cancer
expressed prostatic fluid
zinc
energy-dispersive x-ray fluorescent analysis
Medicine (General)
R5-920
spellingShingle prostate cancer
bladder cancer
expressed prostatic fluid
zinc
energy-dispersive x-ray fluorescent analysis
Medicine (General)
R5-920
Vladimir Zaichick
Sofia Zaichick
Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
description Introduction: In our previous studies it was concluded that the zinc (Zn) level in in human expressed prostatic fluid (EPF) is a first candidate with the role of offering a new, simple, fast, reliable, and non-invasive diagnostic tool for prostate cancer (PCa) screening. However it was unclear how other non-prostatic diseases inherent of the old persons, including heart diseases, atherosclerosis, diabetes, asymptomatic cancer of different localization and some others, impact on a chemical element composition of expressed prostatic fluid. Thus, the purpose of this study was to evaluate whether significant changes in the levels of Zn in EPF exist in patients with bladder cancer (BC). Methods: Prostatic fluid levels of Zn were prospectively evaluated in 17 patients with BC and 51 healthy male inhabitants (control group). Measurements were performed using 109Cd radionuclide-induced energy dispersive X-ray fluorescent microanalysis developed by us. Results: Mean value  standard deviation of mean (MSD) for concentration of Zn in the EPF of healthy males and patients with BC was 573202 mg/L and 625±108 mg/L, respectively. Using both parametric Student’s t-test and non-parametric Wilcoxon-Mann-Whitney U-test it was shown that the Zn concentration in the EPF of patients with BC did not differ from that in healthy subjects. Conclusion: Such serious illness as BC did not impact on the Zn concentration in the EPF.
format article
author Vladimir Zaichick
Sofia Zaichick
author_facet Vladimir Zaichick
Sofia Zaichick
author_sort Vladimir Zaichick
title Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
title_short Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
title_full Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
title_fullStr Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
title_full_unstemmed Zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
title_sort zinc concentrations in the expressed prostatic fluid of patients with bladder cancer
publisher Emergency Department of Hospital San Pedro (Logroño, Spain)
publishDate 2020
url https://doaj.org/article/8a0b5467256b4f20b260e2cdff836c63
work_keys_str_mv AT vladimirzaichick zincconcentrationsintheexpressedprostaticfluidofpatientswithbladdercancer
AT sofiazaichick zincconcentrationsintheexpressedprostaticfluidofpatientswithbladdercancer
_version_ 1718386244273045504